Bio-Techne Corporation (TECH)

Antwerp, Dec. 16, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) (“CMBT”, “CMB.TECH” or “the Company”) is pleased to announce the company is i...

Bamco Inc. NY trimmed its position in Bio-Techne Corp (NASDAQ: TECH) by 14.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund ...

Cerity Partners LLC raised its position in shares of Bio-Techne Corp (NASDAQ: TECH) by 20.3% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commissi...

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced a strategic...

Combines chemiluminescence detection with dual-channel fluorescence in the near-infrared and infrared (NIR and IR) ranges for expanded multiplexing Enables up to 24 targets per sample and supports com...

Bio-Techne Corporation (TECH) Presents at 53rd Annual Nasdaq Investor Conference Transcript...

Brown Advisory Inc. reduced its position in Bio-Techne Corp (NASDAQ: TECH) by 7.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange...

Bio-Techne Corporation (TECH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript...

Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript...

CMB.TECH NV ( CMBT ) Q3 2025 Earnings Call November 26, 2025 8:00 AM EST Company Participants Alexander Saverys - CEO & Member of Management Board Ludovic Saverys - CFO & Member of Management Board En...